I suppose that is it is a good sign that shorts really are beginning to close positions. Let's hope they speed up as we approach December (the release of Interim results). However, it is disconcerting that although short positions have been falling steadily since 7% at end of September there is not a sign yet of the share price going up. If Fidelity is all out perhaps we will see some blue soon.
Was it FIL who lent the shorters the shares in the first place? If it was FIL presumably they won't want the share back - or will they; to sell once more? What a conundrum!!
I got my top up too soon at 47.5p, and my break even is way up.
Who would have thought the price would have fallen so low after the placing at 80p? I guess the big five shorts did and neither Edmund Truell nor Odey could do anything about it - so far!!!
Can they hold the price at 46p until all 7m shorts are cleared?
Why do they trade in dribs and drabs - all the buys are going through at 46p in small lots; I can't understand why they just don't do the whole days block of trading in one go as the price is being held at 46p?
"Nov 4 Oxford Biomedica Plc
* Cash at end October 2015 of £14.9m
* Revenue and other income is now beginning to grow in line with our expectations with July to October being well ahead of first four months of year"
raulc - thanks for your reply.
First I had hoped that with the directors getting options at 67.5p that was the floor and then when lower at 56p on 24th September that was going to be the bottom for TUNG. Looks like I may be in for more pain!!! Luckily I am not desperate to sell but I won't buy any more even if they fall to 40p.
(I am a little peeved that needing to go out with my wife for most of the day - I missed selling my long on GLEN at around 139p).
Roll on 2016 and jam tomorrow!
Wall Street Friday close was very positive; hoping the 5% reversal has a good knock on effect on OXB on Monday:
iShares Nasdaq Biotechnology ETF (IBB) (IBB), closed up 3.4 percent after earlier falling 2 percent.